Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
Assessing walking disability in multiple sclerosis.
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Evaluating the potential benefit of interferon treatment in multiple sclerosis.
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis.
First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.
Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis.
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
N-Acetylcysteine amide: A Derivative to Fulfill the Promises of N-Acetylcysteine.
miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.
Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis.
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis.
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
Biotechnology industry leader Centocor Ortho Biotech is now Janssen Biotech, Inc., part of the Janssen pharmaceutical companies
From injection therapies to natalizumab: views on the treatment of multiple sclerosis.
Regional Cervical Cord Atrophy and Disability in Multiple Sclerosis: A Voxel-based Analysis.

Pages